Results 281 to 290 of about 742,291 (311)
A multicenter observational cohort study in survivors of Down Syndrome-associated acute leukemia (ALTE22C1): a report from the Children's Oncology Group. [PDF]
BMC CancerGramatges MM, Sanclemente LN, Hall L, Taylor OA, Nuño MM, Bhatia S, Chow EJ, Getz KD, Hitzler JK, Li AM, McCloskey K, Nathan PC, O'Brien MM, Patel S, Verma A, Yarbrough AR, Richard MA, Rosser TC, Jacola LM, Lupo PJ, Rabin KR. +20 moreeuropepmc +1 more sourceDefining 2 biologically and clinically distinct groups in acute leukemia with a mixed phenotype. [PDF]
BloodGalera P, Dilip D, Derkach A, Chan A, Zhang Y, Persaud S, Mishra T, Kramer K, Kathpalia M, Liu Y, Famulare C, Gao Q, Mata DA, Arcila M, Geyer MB, Stein E, Dogan A, Roshal M, Levine RL, Glass J, Xiao W. +20 moreeuropepmc +1 more sourceRapid and sensitive acute leukemia classification and diagnosis platform using deep learning-assisted SERS detection. [PDF]
Cell Rep MedZhang D, Cheng Z, Song Y, Li H, Shi L, Wang N, Peng Y, Chen R, Sun N, Han M, Hu F, Zong C, Zhang R, Chen S, Zhu C, Zhang X, Li X, Ma X, Shi C, Zhang X, Liu R, Ren Z, Wang L, Zeng Q, Zeng T, Chen X. +25 moreeuropepmc +1 more sourceAnalysis of Patients With Monocytic and Monocytic‐Like Acute Myeloid Leukemia, Including AML‐M4 and AML‐M5, Treated With Venetoclax Plus Azacitidine
American Journal of Hematology, EarlyView.Marina Konopleva, Courtney D. DiNardo, Yan Sun, Paul Jung, Sanam Loghavi, Jalaja Potluri, Monique Dail, Brenda Chyla, Daniel A. Pollyea +8 morewiley +1 more sourceBasiliximab in the Prophylaxis of aGVHD for Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Thalassemia Major: A Prospective, Multicenter, Open‐Label, Randomized Controlled Study
American Journal of Hematology, EarlyView.Zhenbin Wei, Rongrong Liu, Lingling Shi, Qiaochuan Li, Lianjin Liu, Baoshi Zheng, Chunjie Qin, Hong Chen, Guyun Wang, Meiqing Wu, Gaohui Yang, Ruolin Li, Zhaoping Gan, Qi Zhou, Jing Fan, Xuemei Zhou, Yinghua Chen, Zhiyu Zeng, Zhongming Zhang, Yongrong Lai +19 morewiley +1 more source